Connect with us

Media OutReach

Rethinking Obesity: Novo Nordisk’s Latest Initiative Urges Singaporeans to Treat, Not Blame

Published

on

“Beyond the Scale” focuses on obesity as a chronic disease — urging empathy, early intervention, and evidence-based care.

SINGAPORE – Media OutReach Newswire – 27 June 2025 – Imagine a chronic disease affecting more than 600,000 people 1-3 in Singapore — yet often misunderstood, overlooked, or surrounded by stigma. This is the reality of obesity today. For many, outdated perceptions and delays in care have created barriers to support and treatment. Today, a new initiative is calling for a shift — to change how we think, talk about, and respond to obesity, through a lens of science, empathy, and early intervention.

Novo Nordisk’s ‘Beyond the Scale’ initiative

Breaking the Myths: A Public Health Reframe
“Just eat less.” “Try harder.” “It’s a lifestyle choice.” These are more than just phrases — they reflect a deeper misunderstanding of obesity. Today, a bold new initiative, seeks to challenge those misconceptions and open the door to a more compassionate, evidence-based conversation. “Beyond the Scale” launches across Singapore with a clear and urgent call to focus on obesity as not a failure of willpower, but as a complex, chronic disease. The initiative invites the public to go beyond — beyond stigma, beyond myths, beyond labels — and recognise obesity for what science confirms it to be: a multifactorial health condition that deserves understanding, early intervention, and clinical care.

Led by global healthcare company Novo Nordisk in collaboration with local healthcare professionals and patient advocates, “Beyond the Scale” is a disease awareness initiative aimed at driving a shift in how individuals, communities, and healthcare providers approach obesity management.

“We believe it’s time to shift from blame to understanding,” said General Manager, Mr Vincent Siow of Novo Nordisk Singapore. “Obesity affects 1 out of 9 people in Singapore4, yet it’s still too often seen as a matter of willpower. The reality is that obesity is a complex, chronic disease driven by biology, environment, and unequal access to care.1,5 It’s time we treat it with the seriousness it deserves — and we are proud to lead that conversation and drive meaningful change through the “Beyond the Scale” initiative.

Why This Matters Now
The 2021–2022 National Population Health Survey reveals the highest obesity rate (15%) among adults aged 40 to 49, while 43.3% of residents aged 18 to 74 had abdominal obesity, which increases with age and peaks between 50 to 74 years.6 This is compounded by the fact that perceptions persist about obesity being a personal failing, discouraging individuals from seeking help, delaying diagnosis, and compounding the health burden on families and the healthcare system.

Obesity significantly increases the risk of cardiovascular disease (CVD), type 2 diabetes, and chronic kidney disease (CKD)7, all of which already place a growing strain on Singapore’s healthcare infrastructure. The economic impact is substantial: in 2019, metabolic-risk related diseases, including obesity, diabetes, hypertension, CKD, and cardiovascular conditions, cost Singapore S$2.20 billion.8 Of this, S$642 million were healthcare expenditures8, and excess weight alone accounted for an estimated S$261 million in annual medical and absenteeism costs.9 Without decisive public health action, these obesity-related comorbidities are poised to escalate into a major societal and economic burden.

“This is not just a personal issue — it’s a public health priority,” said Dr Ben Ng, Arden Diabetes & Endocrine Clinic. “We know obesity changes how the body regulates appetite, energy storage, and metabolism. It’s a disease, not a choice. Science supports this — and our response should reflect it.”

The Science Behind the Message
Obesity is not simply about calories in and out. Research confirms it involves neuroendocrine (hormonal), genetic, and psychosocial factors, making it both preventable and treatable10 .

Studies show that in Singapore, weight stigma is often driven by the belief that obesity is a personal failing, lack of willpower, or lifestyle choice leading to delayed treatment, reduced care-seeking, and poorer health outcomes, particularly in managing chronic conditions such as cardiovascular and kidney disease.11

Beyond Labels, Toward Lasting Change
“Beyond the Scale” is more than a slogan — it is a call to treat obesity as the complex, chronic disease that it is. To move away from blame, appearance-based judgments, and oversimplified narratives, toward empathy, science, and sustained health. It is an urgent appeal to rethink, retrain, and rehumanise the way we support individuals living with obesity.

“The earlier we intervene, the better the outcomes,” said Dr. Ng. “Obesity is not a character flaw. It’s a disease. And it’s time we responded with the same respect, science, and care we give every other chronic condition.”

“Beyond the Scale” aims to:

  • Raise awareness of obesity as a chronic, multifactorial disease.
  • Reduce stigma and myths that hinder early care.
  • Encourage timely, evidence-based conversations with healthcare professionals.
  • Promote empathy and science within the medical community.
  • Support patients with tools to take charge of their health.

Singaporeans can participate by:

  • Visiting [www.truthaboutweight.sg] for factual resources, use a BMI measurement tool, and locate a nearest weight management healthcare professional.
  • Starting honest conversations with GPs, nurses, and pharmacists.
  • Sharing content to help dismantle myths and support loved ones on their health journeys.

1. Cuciureanu M, Caratașu CC, Gabrielian L, Frăsinariu OE, Checheriță LE, Trandafir LM, Stanciu GD, Szilagyi A, Pogonea I, Bordeianu G, Soroceanu RP, Andrițoiu CV, Anghel MM, Munteanu D, Cernescu IT, Tamba BI. 360-Degree Perspectives on Obesity. Medicina (Kaunas). 2023 Jun 9;59(6):1119. doi: 10.3390/medicina59061119. PMID: 37374323; PMCID: PMC10304508.​

2. World Obesity. Retrieved from https://www.worldobesity.org/about/about-obesity/prevalence-of-obesity

3. World Obesity. Retrieved from https://data.worldobesity.org/country/singapore-192/

4. Lee, Y. V., & Tan, N. C. (2014). Obesity in Singapore: An update. The Singapore Family Physician, 40(2), 11–16. https://cfps.org.sg/publications/the-singapore-family-physician/article/71_pdf

5. World Health Organization. (2024). Obesity and overweight.WHO.https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight As accessed on 22nd May 2025.

6. Ministry of Health, Singapore. (2022). National Population Health Survey 2022 Report. https://isomer-user-content.by.gov.sg/3/28c3b8f9-9216-46be-8fc9-b614098666a9/nphs-2022-survey-report_final.pdf

7. Cohen JB, Cohen DL. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome. Curr Hypertens Rep. 2015 May;17(5):34. doi: 10.1007/s11906-015-0544-2. PMID: 25833456; PMCID: PMC4427189.

8. Tan, V., Lim, J., Akksilp, K. et al. The societal cost of modifiable risk factors in Singapore. BMC Public Health 23, 1285 (2023). https://doi.org/10.1186/s12889-023-16198-2 (2.2 Billion)

9. Junxing C, Huynh VA, Lamoureux E, Tham KW, Finkelstein EA. Economic burden of excess weight among older adults in Singapore: a cross-sectional study. BMJ Open. 2022 Sep 16;12(9):e064357. doi: 10.1136/bmjopen-2022-064357. PMID: 36113947; PMCID: PMC9486358.

10. Bray GA, Kim KK, Wilding JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017 Jul;18(7):715-723. doi: 10.1111/obr.12551. Epub 2017 May 10. PMID: 28489290.

11. Goff AJ, Lee Y, Tham KW. Weight bias and stigma in healthcare professionals: a narrative review with a Singapore lens. Singapore Med J. 2023 Mar;64(3):155-162. doi: 10.4103/singaporemedj.SMJ-2022-229. PMID: 36876621; PMCID: PMC10071861.

Hashtag: #NovoNordisk

The issuer is solely responsible for the content of this announcement.

About Novo Nordisk

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs around 77,400 people in 80 countries and markets its products in around 170 countries. In Singapore, Novo Nordisk has been present since 1997 and has approximately 100 employees.

“Beyond the Scale” campaign builds on Novo Nordisk’s long-standing commitment to tackling chronic diseases. With over 100 years of experience advancing care for diabetes and more than 25 years of focused obesity research, Novo Nordisk is pioneering the medical management of obesity and the science of the GLP-1 hormone — a naturally occurring signal that regulates appetite and plays a key role in achieving sustained weight loss.

As part of its mission to drive long-term health outcomes, Novo Nordisk is also investing in scalable prevention efforts. Through the Cities for Better Health initiative — a global public-private partnership spanning over 50 cities — Novo Nordisk is working to reduce chronic disease risk in vulnerable urban communities. Its latest programme, the Childhood Obesity Prevention Initiative (COPI), delivers targeted interventions to promote healthier diets and physical activity among children aged 6–13 in underserved areas.

In Singapore and beyond, these initiatives reinforce Novo Nordisk’s holistic approach: treating obesity with medicine and empathy today, while building healthier environments for the next generation.

For more information, visit novonordisk.sg.

Advertisement

Media OutReach

VinFast Officially Enters Indonesia’s E-Scooter Market, Partners with Strategic Dealers

Published

on

HANOI, VIETNAM – Media OutReach Newswire – 10 February 2026 – VinFast today officially announced its entry into Indonesia’s e-scooter market through the signing of a Memorandum of Understanding (MoU) with strategic dealers in the country. The milestone marks a significant step in VinFast’s international expansion of its electric two-wheeler business and reaffirms the Company’s long-term commitment to one of Southeast Asia’s largest and most dynamic motorcycle markets.

VinFast signed strategic MoUs with its first e-scooter partners in Indonesia.

Accordingly, VinFast has signed strategic MoUs with its first partners in Indonesia, including K3, Citra Abadi Sedaya, PT Bevos Auto Mandiri, PT Sapta Jaya, MotorArt, PT Sinergies Dua Kawan, and PT HINU. These partners have long-standing experience in the distribution of automobiles and motorcycles, strong professional operational capabilities, deep market understanding, and the ability to rapidly deploy operations in line with VinFast’s standards.

VinFast will begin rolling out its distribution network in the Jabodetabek area — Indonesia’s largest economic and urban center — from the second quarter of 2026, with plans to expand to other regions nationwide.

In Indonesia, VinFast plans to introduce a portfolio of battery-swapping e-scooters, including VinFast Evo, VinFast Feliz II, VinFast Flazz and VinFast Viper, alongside additional new models to be launched in due course. The product lineup has been carefully engineered and calibrated to suit Indonesia’s tropical climate, dense urban traffic conditions, and everyday commuting patterns.

Throughout 2026, VinFast aims to further expand its footprint to hundreds of authorized dealerships and service workshops nationwide. The Company’s development strategy in Indonesia is designed as an integrated ecosystem, combining retail and after-sales networks, financing solutions, charging and battery-swapping infrastructure through cooperation with V-Green, and partnerships with leading financial institutions.

Prior to this announcement, VinFast had unveiled its strategy to internationalize its electric two-wheeler business and signed agreements with dealers in the Philippines. According to its roadmap, the Company will accelerate expansion across five priority markets in 2026, namely the Philippines, Indonesia, India, Thailand, and Malaysia. These countries represent high-growth economies with substantial urban mobility demand and a clear transition toward sustainable transportation solutions.

Ms. Vo Thi Cam Tu, Managing Director of VinFast E-Scooters Overseas Market, stated: “Indonesia is a strategic market in VinFast’s global e-scooter expansion journey. Partnering with leading local dealers underscores our partners’ confidence in VinFast’s product quality, service standards, flexible battery-swapping model, and long-term vision. We are committed to accompanying Indonesian consumers on their transition toward a greener, smarter, and more sustainable future of mobility.”

Indonesia stands among the world’s largest motorcycle markets, characterized by rapid urbanization, high population density in major cities, and increasing policy and consumer momentum toward environmentally friendly transportation. These structural factors create substantial headroom for the growth of the e-scooter segment. Indonesian dealers have expressed strong confidence in VinFast’s long-term potential in the country, citing its comprehensive green mobility ecosystem, large-scale manufacturing capabilities, and proven ability to execute swiftly across multiple international markets.

After two years of presence in Indonesia, VinFast has introduced a broad range of electric vehicles, from electric SUVs to models optimized for transportation services, and has commenced operations at its Subang facility. Concurrently, the Company has expanded its integrated ecosystem, including dealership and after-sales networks, charging infrastructure in collaboration with V-Green, and partnerships with leading banks and financial institutions. Through pioneering and customer-centric policies, VinFast continues to lower barriers to EV adoption and enable Indonesian consumers to participate in the global green mobility revolution.

Hashtag: #VinFast

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

Voicecomm Technology Wins 300 million RMB Major “AI+ Elderly Care” Project Forging a New Engine for the Silver Economy

Published

on

HONG KONG SAR – Media OutReach Newswire – 9 February 2026 – Voicecomm Technology Co., Ltd. (“Voicecomm Technology” or the “Company”, Stock Code: 2495.HK), one of the leading enterprises in Conversational Artificial Intelligence (CoAI), is pleased to announce that it has successfully won the bid for the “South Sichuan Intelligent Valley AI Vertical Large Model Innovation Platform (川南智谷人工智能垂直大模型創新平台)- Silver Economy Construction and Operation Project” in Neijiang City, Sichuan Province. The total contract value is close to 300 million RMB, including approximately RMB 150 million for the initial platform construction costs; and approximately RMB 140 million for medium- to long-term project operation costs. This indicates that Voicecomm Technology has successfully established a full-stack service closed loop of “construction + operation”. This project marks a significant breakthrough for the Company in pioneering the new strategic track of “AI + healthcare” and represents its first replicable city-level smart elderly care benchmark project.

According to report from iResearch, as the end of 2024, China’s population aged 60 and above has exceeded 310 million, accounting for 22.0% of the total population. As the first city-level AI elderly care project, this not only affirms Voicecomm Technology’s position in the “AI + Elderly Care” sector but also signals a new trend in government investment towards smart elderly care—shifting from infrastructure construction to pursuing effective operational services.

Mr. Sun Qi, Founder and Executive Director of Voicecomm Technology Co., Ltd., said: “China is accelerating into a phase of deep aging, and the needs of hundreds of millions of elderly people constitute a vast blue ocean. Faced with the challenges of an aging society today, we aim to leverage artificial intelligence technology to explore a new, scientifically-driven path for elderly care. The Neijiang project is our first demonstration project in the healthcare sector. Its core lies not in stacking hardware but in using AI as the engine to make elderly care services truly intelligent and smooth, thereby enhancing the quality of life and dignity of the elderly. We hope to build this project into a replicable model for more cities to learn from.”

This project is expected to become a powerful engine for activating the silver economy in Neijiang City. Guided by national Smart Elderly Care policies, the project is anticipated to drive an annual output value exceeding 1 billion RMB in the local elderly care service industry and create a large number of job opportunities. By establishing a unified smart health and elderly care service platform, the project will strive to build a “15-minute elderly care service circle,” achieving deep integration between technology and people’s livelihoods.

Since its establishment in 2005, Voicecomm Technology has been committed to the research and application of Conversational Artificial Intelligence and unified communications technologies. Its solutions cover multiple scenarios in fields such as city management and administration, automotive and transportation, telecommunications, finance, healthcare, and energy management. This successful bid once again unveils Voicecomm Technology’s commitment to promoting technological progress and social development.

Hashtag: #Voicecomm

The issuer is solely responsible for the content of this announcement.

Voicecomm Technology Co., Ltd.

Founded in 2005 and headquartered in Wuhan, Voicecomm Technology is one of the leading enterprises in the field of Conversational Artificial Intelligence (CoAI) listed on the Main Board of the Hong Kong Stock Exchange, and obtained the qualification as National-level “Little Giant” Enterprise and High-Tech Enterprise. Leveraging advanced unified communication technologies, core conversational AI technologies and self-developed product engines, we are capable of addressing diverse enterprise demand across “collaborative communication”, “intelligent decision-making”, and “efficient execution”, delivering a one-stop enterprise level intelligent interaction experience. Our solutions have been widely adopted in key industries including city management and administration, automotive and transportation, telecommunications, finance, healthcare, and energy management, empowering clients in digital transformation and business innovation.

Continue Reading

Media OutReach

Pacific Century Premium Developments Limited announces annual results for the financial year ended December 31, 2025

Published

on

HONG KONG SAR – Media OutReach Newswire – 9 February 2026

2025 Annual Results – Financial Highlights

(Figures for the corresponding period in 2024 are shown in brackets)

  • Consolidated revenue: HK$1,046million (HK$695million)
  • Consolidated net loss attributable to equity holders of the Company:
    HK$69 million (HK$230million)
  • Basic loss per share: 3.38 HK cents (11.29 HK cents)
  • No final dividend (No final dividend)

Pacific Century Premium Developments Limited (“PCPD”, SEHK: 00432) has announced its annual results for the year ended December 31, 2025.

The consolidated revenue of PCPD and its subsidiaries (together, the “Group”) amounted to HK$ 1,046 million, representing an increase of 51% compared to the revenue of HK$ 695 million in 2024.

The consolidated net loss attributable to equity holders of the Company for the year of 2025 was HK$ 69 million, compared to the net loss of HK$ 230 million in 2024.

Basic loss per share for 2025 was 3.38 Hong Kong cents compared to the loss per share of 11.29 Hong Kong cents for the previous year.

The Board of Directors has not recommended the payment of a final dividend for the year ended December 31, 2025.

In 2025, PCPD achieved robust full-year results, driven by the sustained surge in international travel across our key Asian markets, our operational strengths, and the continued recognition of our high-quality portfolio. This performance was underpinned predominantly by contributions from two segments: Park Hyatt Niseko, Hanazono, our hospitality business in Hokkaido, which delivered a notable rise in occupancy and revenue, and our ski and recreation operations in Niseko, Hokkaido, which also saw a surge in demand and revenue.

Park Hyatt Niseko, Hanazono, our hotel operations in Hokkaido, delivered a robust performance in 2025, as the boom in Japans tourism sector continued throughout the year, again with record-breaking tourist arrivals. The average occupancy rate of Park Hyatt Niseko increased by 4 percentage points.

During the winter season of 2024/2025, total ski-lift and gondola rides increased 9% year-on-year. The travel surge continued to drive robust demand for our recreational business in Niseko well beyond the cold months.

In Phang Nga, Thailand, the Group has sold or reserved 40% of Phase 1A villas. The Group’s revenue from its property development in Thailand totalled HK$14 million for the year ended December 31, 2025, compared to no revenue in 2024.

We formed a strategic alliance with Hotel Properties Limited in Singapore to bring a Four Seasons Resort and Branded Residences to the prestigious integrated resort community of Aquella in Phang Nga. The move represents a significant milestone in PCPDs long-term vision of transforming Aquella into a visionary integrated resort destination that effortlessly blends luxury living, recreation and exceptional service.

In Jakarta, Indonesia, the occupancy of our premium commercial building, Pacific Century Place, Jakarta (PCP Jakarta”), was stable throughout the year, and the project remained a consistent revenue contributor to the Group. As of December 31, 2025, the office space committed occupancy was 87%, compared to 85% in the previous year.

Development of the superstructure of the Groups project at 3–6 Glenealy, Central, Hong Kong, has been progressing well. We have reached a key structural milestone, with the superstructural work now completed and installation of the curtain walls progressing at pace. The name of the development has also been unveiled as Central Residence by the Park”, and its completion is scheduled for the first half of 2026.

In the long run, we remain cautiously optimistic about the long-term outlook for property sectors in Hong Kong, Japan, Thailand and Indonesia. With PCPDs disciplined execution and proactive risk management, we have confidence in our ability to drive continued growth and deliver sustained value.

Mr. Benjamin Lam, PCPD’s Deputy Chairman and Group Managing Director, said: “We will maintain our prudent yet proactive approach, allocating resources carefully and pursuing value-enhancing initiatives. Our priority remains to drive sustainable growth, improve profitability, and deliver solid returns to shareholders and stakeholders.”

Hashtag: #PacificCenturyPremiumDevelopments

The issuer is solely responsible for the content of this announcement.

About PCPD

Pacific Century Premium Developments Limited (“PCPD” or the “Group”, SEHK: 00432) is principally engaged in the development and management of premium-grade property and infrastructure projects as well as premium-grade property investments. PCCW Limited (“PCCW”, SEHK: 00008) is the single largest shareholder of the Group.

Continue Reading

Trending